Switch View
© PR Newswire
25.09.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
News Preview
- Transaction designed to accelerate development of RT234 (vardenafil Inhalation powder), an investigational first-in-class, as-needed (PRN) treatment for PAH and PH-ILD -
PALO ALTO, Calif., Sept. 25, 2025 /PRNewswire/ -- Respira Therapeutics, Inc. (Respira or the "Company"), a Samsara BioCapital portfolio company, today announced that it has ent...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced it has entered into an option agreement to acqu...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA71719L1067
Pharmala Biotech Holdings Inc.
MDMA
LISTED
CSE
PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand
News Preview
TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has signed a distribution agreement with Veridio...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
25.09.2025
ISIN: US0345691036
Anebulo Pharmaceuticals, Inc.
ANEB
LISTED
NASDAQ
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
News Preview
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company” or “Anebulo”), today announces the first subjects dosed in its Phase 1 single ascending dose (“SAD”) study of intravenous (IV) selonabant in healthy young...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
25.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
QULIPTA® (atogepant) Now Publicly Reimbursed in Quebec for Chronic Migraine and CGRP Class Review Published
News Preview
- Expanded access provides an additional treatment option for those with chronic migraine.- AbbVie is dedicated to people living with this debilitating disease and continues its commitment by providing multiple treatments and programs for these individuals.
MONTREAL, Sept. 25, 2025 /CNW/ - AbbVie (NYSE: ABBV) announced today tha...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
News Preview
-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access -- -- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant marke...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US42226A1079
Healthequity Inc
HQY
LISTED
NASDAQ
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
News Preview
New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: CA90429T1003
Unbuzzd Wellness Inc.
UNBZ
LISTED
CSE
Unbuzzd Wellness Raising Up To $5 Million USD Through Reg D 506 (c) Offering; Hosting Live Webinar and Q&A for Interested Accredited Investors on Wednesday, October 1, 2025 at 4:30 PM EST (1:30 PM PST)
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms — today announced...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its direct-to-patient offerings, providing eligible U.S. patients with steeply discounted prices for Eliquis® (apixaban) and Sotyktu® (deucravacitinib). Eligible cash-pay patients can now purchase these medicines directly from BMS and significantly lower their out-of-pocket costs....
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
News Preview
Pfizer Inc. (NYSE: PFE) will highlight data across its extensive Oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025, being held October 17-21 in Berlin, Germany. Data from more than 45 company-sponsored, investigator-sponsored, and collaborative research abstracts, including 11 oral/mini oral presentations and fiv...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Counterpart Assistant Gets Conversational
News Preview
New generative AI capabilities help physicians prep faster, manage complexity and deliver high-quality value-based care at scale New generative AI capabilities help physicians prep faster, manage complexity and deliver high-quality value-based care at scale...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
News Preview
WARREN, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced significant progress in the development of its proprietary PredicTcell™ platform, designed to accelerate precision immunotherapy development and efficacy through advanced machine learning and transformer-based models...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
25.09.2025
ISIN: US45826H1095
Integer Holdings Corp
ITGR
LISTED
NYSE
Integer Announces Conference Call to Discuss Third Quarter 2025 Results
News Preview
PLANO, Texas, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the third quarter ended Sept. 26, 2025, on Thursday, Oct. 23, 2025, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information ma...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatmen...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Smash Burger Brand Rosie's Burgers Secures 1st Real Estate Location in Quebec
News Preview
Toronto, Ontario--(Newsfile Corp. - September 25, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Carma Hospitality has secured a real estate location for their first Quebec-based Rosie's Burgers ("Rosie's") in the nei...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
News Preview
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting
News Preview
SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced a regulatory update for its Biologics License Application (BLA) for Deramiocel, the Company’s investigational cell therapy for the treatment of...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA01559R1038
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection
News Preview
VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and financing agreement with Catalyst MedTech for the provision of four, U.S. FDA cleared O...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025
News Preview
NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the first...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US6551872012
Aclarion, Inc.
ACON
LISTED
NASDAQ
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
News Preview
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
News Preview
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globally SAN FRANCISCO, CA / ACCESS Newswire / September 25, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the ve...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts
News Preview
MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI Facial Health Risk Estimator now includes early detection and monitoring of glaucoma and cataracts, two leading causes of vision loss globally.Using high-resolution facial and ocular image analysis, the platform detects:Cornea...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships
News Preview
NEW YORK CITY, NEW YORK / ACCESS Newswire / September 25, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery company and parent of wholly owned subsidiary BioSymetrics, today announced advancement of its biomarker discovery preclinical program in Parkinson's Disease. The initiative leverages BioSymetrics' proprietary Augusta Pla...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0000032526
Guerbet SA
GBT
LISTED
EURONEXT
GUERBET : Mise à disposition du rapport financier semestriel 2025
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CH0011432447
Basilea Pharmaceutica AG Allschwil
BSLN
LISTED
SIX
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
News Preview
- Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of USD 6 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron announces the acquisition of UCP in North America and FDA inspection update
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 25 September 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031
News Preview
KalVista Pharmaceuticals, Inc. (“KalVista”) (NASDAQ: KALV), announced today the pricing of its offering of $125.0 million aggregate principal amount of 3.250% Convertible Senior Notes due 2031 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Pricing of $100 Million Public Offering
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the pricing of an underwritten offering of 31,250,000 shares of its common stock at a price to the public of $3...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi
News Preview
Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Shareholders Who Lost Money in LNTH Should Contact Robbins LLP for Information About Leading the Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Lantheus Holdings, Inc. (NASAQ: LNTH) securities between February 26, 2025 and August 5, 2025. Lantheus is a global company that develops, manufactures, sells, and distribu...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Shareholders Who Lost Money in SVRA Should Contact Robbins LLP for Information About Leading the Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Savara Inc. (NASAQ: SVRA) securities between March 7, 2024 and May 23, 2025. Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. The...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Inc. Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the CYTK Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. Cytokinetics is a biopharmaceutical company focused on discovering, developing, and...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Summary Notice of Proposed Settlement of Derivative Actions
News Preview
LEHI, Utah, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Owlet, Inc. (NYSE:OWLT) has released the following notice:...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO
News Preview
NEW YORK, Sept. 24, 2025 Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting from allegations that Soleno Therapeutics may have issued materially misleading business information to the investing public....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US55287L1017
MBX Biosciences, Inc.
MBX
LISTED
NASDAQ
MBX Biosciences Announces Pricing of Upsized Public Offering
News Preview
CARMEL, Ind., Sept. 24, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the pricing of its upsized public offering of 11,108,055 shares of it...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
News Preview
Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW).
If you currently own shares of Edwards stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=29704 for more information. Y...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Sept. 24, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Sept. 24, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces New Employment Inducement Grants
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 9,750 shares of the Com...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced the grant of inducement awards of options to purchase a collective total of up to 65,750 shares of common stock. Awards were made to eight new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare, Inc. 3rd Quarter 2025 Earnings Conference Call
News Preview
HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What:
HCA Healthcare, Inc. 3Q 2025 Earnings Call
When:
Friday, October 24, 2025 at 9:00 AM Central (10:00 AM Eastern)
How:
Live Audio over the Internet:
https://investor.hcahealthcare.com/events-and-presentations/default.aspx...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Incyte (Nasdaq:INCY) announced today equity inducement awards grants to David H. Gardner, the Company’s new Executive Vice President, Chief Strategy Officer, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awards were approved by the compensation committee of the Company’s Board of Directors as an inducement material to the new...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Proposed Public Offering
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it has commenced an underwritten public offering of its common stock and, in lieu of common stock to certa...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, announced positive clinical data today from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 Phase 1 single ascending dose (...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Summary Notice of Proposed Settlement of Derivative Actions
News Preview
Owlet, Inc. (NYSE: OWLT) has released the following notice:
IN THE UNITED STATES DISTRICT COURT
FOR THE CENTRAL DISTRICT OF CALIFORNIA
IN RE OWLET, INC. SHAREHOLDER DERIVATIVE LITIGATION
Lead Case No.
2:24-cv-07258-FLA-PVC
This Document Relates to:
ALL ACTIONS.
NOTICE OF PROPOSED DERIVATIVE SETTLEME...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Announces Proposed Offering of $110.0 Million of Convertible Senior Notes
News Preview
KalVista Pharmaceuticals, Inc. (“KalVista”) (NASDAQ: KALV) announced today that it intends to offer, subject to market conditions and other factors, $110.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare announces cash dividend for third quarter of 2025
News Preview
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14, 2025 to all shareholders of record as of October 24, 2025.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US7402944000
Precision Optics Corp, Inc.
POCI
LISTED
NASDAQ
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025
News Preview
GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and fiscal year...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between D...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law Firm
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
News Preview
At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1.73m2 ( p<0.0001)Imlifidase was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission of a...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Kuehn Law Encourages Investors of Sarepta Therapeutics, Inc. to Contact Law Firm
News Preview
NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
News Preview
At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1.73m2 ( p<0.0001)Imlifidase was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission of a...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure Announces $200 Million Proposed Public Offering
News Preview
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $200 million underwritten public offering of its ordinary shares and, in lieu of ordinary shares to certai...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
News Preview
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Placement to Sanofi...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Inc. to Present at the MicroCap Rodeo Conference
News Preview
Thursday, September 25, 2025 in New York City Thursday, September 25, 2025 in New York City...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US28617K1016
Eledon Pharmaceuticals, Inc.
ELDN
LISTED
NASDAQ
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
News Preview
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
News Preview
GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to its leadership combating the opioid crisis through a multi-faceted approach focused on awareness, education and...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
